Neil Patrick O'malley, MD | |
17 Western Maryland Pkwy, Suite 100, Hagerstown, MD 21740-5471 | |
(301) 797-9240 | |
(301) 797-4234 |
Full Name | Neil Patrick O'malley |
---|---|
Gender | Male |
Speciality | Neurosurgery |
Experience | 35 Years |
Location | 17 Western Maryland Pkwy, Hagerstown, Maryland |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1225055858 | NPI | - | NPPES |
W2660002 | Other | MD | BLUE SHIELD REGIONAL-MD |
966244 | Other | PA | PA BLUE SHIELD PA LOCATIO |
140005758 | Other | RR MEDICARE | |
P00670421 | Other | PA | RR MEDICARE |
149523 | Other | PA | PA BLUE SHIELD MD LOC |
54359603 | Other | MD | MD BLUE SHIELD |
593901100 | Medicaid | MD |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207T00000X | Neurological Surgery | MD045409L (Pennsylvania) | Secondary |
207T00000X | Neurological Surgery | D0050813 (Maryland) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Meritus Medical Center | Hagerstown, MD | Hospital |
Chambersburg Hospital | Chambersburg, PA | Hospital |
Waynesboro Hospital | Waynesboro, PA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Wellspan Medical Group | 1951213115 | 1946 |
Wellspan Medical Group | 1951213115 | 1946 |
News Archive
Life-threatening heart damage is an adverse side effect of the cancer drug doxorubicin, damage that also limits the use of newer chemotherapeutic agents such as trastuzumab and imatinib. The ability to protect the heart from these side effects would benefit patients, including cancer survivors who are at risk of developing heart damage years later, and it also could allow safer use of these drugs at higher doses.
Life Technologies Corporation and OpGen, Inc., a commercial stage whole genome analysis company, today announced that they have signed a collaboration agreement to develop systems, technologies and applications intended to improve the management and surveillance of microbial outbreaks in the public health and infectious disease markets.
Approximately one-third of the world's population is infected with Mycobacterium tuberculosis, the bacterium that causes TB, and an estimated 1.6 million people died of the disease in 2005.
Researchers at Northwestern University Feinberg School of Medicine have identified in mice a previously unknown protective mechanism by which the smallest blood vessels remove blood clots and other blockages from the brain. The findings provide insights into mechanisms that may be involved in age-related cognitive decline, Alzheimer's disease and recovery from stroke.
› Verified 2 days ago
Entity Name | Parkway Neuroscience And Spine Institute Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1609896067 PECOS PAC ID: 5890688659 Enrollment ID: O20040205000270 |
News Archive
Life-threatening heart damage is an adverse side effect of the cancer drug doxorubicin, damage that also limits the use of newer chemotherapeutic agents such as trastuzumab and imatinib. The ability to protect the heart from these side effects would benefit patients, including cancer survivors who are at risk of developing heart damage years later, and it also could allow safer use of these drugs at higher doses.
Life Technologies Corporation and OpGen, Inc., a commercial stage whole genome analysis company, today announced that they have signed a collaboration agreement to develop systems, technologies and applications intended to improve the management and surveillance of microbial outbreaks in the public health and infectious disease markets.
Approximately one-third of the world's population is infected with Mycobacterium tuberculosis, the bacterium that causes TB, and an estimated 1.6 million people died of the disease in 2005.
Researchers at Northwestern University Feinberg School of Medicine have identified in mice a previously unknown protective mechanism by which the smallest blood vessels remove blood clots and other blockages from the brain. The findings provide insights into mechanisms that may be involved in age-related cognitive decline, Alzheimer's disease and recovery from stroke.
› Verified 2 days ago
Entity Name | Wellspan Medical Group |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1750480299 PECOS PAC ID: 1951213115 Enrollment ID: O20040220000815 |
News Archive
Life-threatening heart damage is an adverse side effect of the cancer drug doxorubicin, damage that also limits the use of newer chemotherapeutic agents such as trastuzumab and imatinib. The ability to protect the heart from these side effects would benefit patients, including cancer survivors who are at risk of developing heart damage years later, and it also could allow safer use of these drugs at higher doses.
Life Technologies Corporation and OpGen, Inc., a commercial stage whole genome analysis company, today announced that they have signed a collaboration agreement to develop systems, technologies and applications intended to improve the management and surveillance of microbial outbreaks in the public health and infectious disease markets.
Approximately one-third of the world's population is infected with Mycobacterium tuberculosis, the bacterium that causes TB, and an estimated 1.6 million people died of the disease in 2005.
Researchers at Northwestern University Feinberg School of Medicine have identified in mice a previously unknown protective mechanism by which the smallest blood vessels remove blood clots and other blockages from the brain. The findings provide insights into mechanisms that may be involved in age-related cognitive decline, Alzheimer's disease and recovery from stroke.
› Verified 2 days ago
Mailing Address | Practice Location Address |
---|---|
Neil Patrick O'malley, MD 3421 Concord Rd, York, PA 17402-9001 Ph: (301) 797-9240 | Neil Patrick O'malley, MD 17 Western Maryland Pkwy, Suite 100, Hagerstown, MD 21740-5471 Ph: (301) 797-9240 |
News Archive
Life-threatening heart damage is an adverse side effect of the cancer drug doxorubicin, damage that also limits the use of newer chemotherapeutic agents such as trastuzumab and imatinib. The ability to protect the heart from these side effects would benefit patients, including cancer survivors who are at risk of developing heart damage years later, and it also could allow safer use of these drugs at higher doses.
Life Technologies Corporation and OpGen, Inc., a commercial stage whole genome analysis company, today announced that they have signed a collaboration agreement to develop systems, technologies and applications intended to improve the management and surveillance of microbial outbreaks in the public health and infectious disease markets.
Approximately one-third of the world's population is infected with Mycobacterium tuberculosis, the bacterium that causes TB, and an estimated 1.6 million people died of the disease in 2005.
Researchers at Northwestern University Feinberg School of Medicine have identified in mice a previously unknown protective mechanism by which the smallest blood vessels remove blood clots and other blockages from the brain. The findings provide insights into mechanisms that may be involved in age-related cognitive decline, Alzheimer's disease and recovery from stroke.
› Verified 2 days ago
Sandip M Savaliya, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 17 Western Maryland Pkwy Ste 100, Hagerstown, MD 21740 Phone: 301-797-9240 Fax: 301-797-4234 | |
Dr. Michael G Radley, M.D. Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 17 Western Maryland Pkwy, Hagerstown, MD 21740 Phone: 301-797-9240 Fax: 301-797-4119 | |
Charles J Winters, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 17 Western Maryland Pkwy, Hagerstown, MD 21740 Phone: 301-797-9240 Fax: 301-797-4234 | |
Dr. John R Caruso, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 17 Western Maryland Pkwy, Hagerstown, MD 21740 Phone: 301-797-9240 Fax: 301-797-4119 | |
Grace Mooney, M.D. Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 17 Western Maryland Pkwy, Suite 100, Hagerstown, MD 21740 Phone: 301-797-6389 Fax: 301-754-0388 | |
Dr. Brian Holmes, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 17 Western Maryland Pkwy, Suite 100, Hagerstown, MD 21740 Phone: 301-797-9240 Fax: 301-797-4234 |